Integral Diagnostics Limited (ASX:IDX – Get Free Report) insider Raelene Murphy purchased 15,000 shares of the stock in a transaction dated Tuesday, March 11th. The shares were acquired at an average price of A$2.36 ($1.48) per share, with a total value of A$35,400.00 ($22,264.15).
Integral Diagnostics Stock Performance
The firm has a market capitalization of $1.10 billion, a PE ratio of -11.45, a PEG ratio of 1.39 and a beta of 0.73. The company has a quick ratio of 1.84, a current ratio of 0.86 and a debt-to-equity ratio of 118.59.
Integral Diagnostics Dividend Announcement
The company also recently declared a Interim dividend, which will be paid on Sunday, April 6th. Stockholders of record on Sunday, April 6th will be issued a $0.025 dividend. This represents a dividend yield of 1.06%. The ex-dividend date of this dividend is Wednesday, March 5th. Integral Diagnostics’s dividend payout ratio (DPR) is -23.08%.
Integral Diagnostics Company Profile
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Further Reading
- Five stocks we like better than Integral Diagnostics
- Insider Buying Explained: What Investors Need to Know
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to trade using analyst ratings
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Why Invest in High-Yield Dividend Stocks?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.